bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution

Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system th [...]

April 13th, 2022|News|

Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions

SALT LAKE CITY, UTAH (December 14, 2021) – Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has signed an exclusive Asia-Pacific and Oceania region distribution agreement with PerkinElmer, Inc. a global leader committed to [...]

December 14th, 2021|News|

Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers

Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global [...]

December 13th, 2021|News|

Cell Microsystems Completes $10M Growth Financing

Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced the closing of a $10 million financing from Telegraph Hill Partners (“THP”), a life science ventur [...]

November 15th, 2021|News|

Specific Diagnostics Announces the First Purchase Orders in Europe

October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced it has signed multi-year reagent rental agreements with two clinical microbiology laboratories in France, marking the commercialization of Specific’s transformative Reveal rapid AST instrument. T [...]

October 4th, 2021|News|

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced t [...]

September 14th, 2021|News|